[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Colchicine and Standard of care for the treatment of SARS-CoV-2 infection: All patients will be receiving loading dose of 1mg and thereafter once daily oral colchicine 0.5mg for a period of at least 3 weeks or till clinical improvement.Control Intervention1: The standard of care treatment of SARS-CoV-2 infection: The Standard of care for COVID infection as per institution protocol are:1.To give prophylactic anti-coagulation with unfractionated heparin- if D-dimer more than 500; presence of risk factors for thrombotic disease; in all patients with moderate to severe COVID infections.2.To give therapeutic anticoagulation with unfractionated heparin if there is evidence of thromboembolism or high suspicion of thromboembolism. 3.If the patient is requiring oxygen to give Dexamethasone injection 6mg intravenously once daily for minimum duration of 10 days. 4.If significant respiratory support requirement; to consider prone ventilation; non-invasive or invasive ventilatory support and ICU care as needed.Other symptomatic and supportive measures", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Colchicine and Standard of care for the treatment of SARS-CoV-2 infection: All patients will be receiving loading dose of 1mg and thereafter once daily oral colchicine 0.5mg for a period of at least 3 weeks or till clinical improvement.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: The standard of care treatment of SARS-CoV-2 infection: The Standard of care for COVID infection as per institution protocol are:1.To give prophylactic anti-coagulation with unfractionated heparin- if D-dimer more than 500; presence of risk factors for thrombotic disease; in all patients with moderate to severe COVID infections.2.To give therapeutic anticoagulation with unfractionated heparin if there is evidence of thromboembolism or high suspicion of thromboembolism. 3.If the patient is requiring oxygen to give Dexamethasone injection 6mg intravenously once daily for minimum duration of 10 days. 4.If significant respiratory support requirement; to consider prone ventilation; non-invasive or invasive ventilatory support and ICU care as needed.Other symptomatic and supportive measures", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 310, "treatment_name": "Colchicine", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Colchicine and Standard of care for the treatment of SARS-CoV-2 infection: All patients will be receiving loading dose of 1mg and thereafter once daily oral colchicine 0.5mg for a period of at least 3 weeks or till clinical improvement.Control Intervention1: The standard of care treatment of SARS-CoV-2 infection: The Standard of care for COVID infection as per institution protocol are:1.To give prophylactic anti-coagulation with unfractionated heparin- if D-dimer more than 500; presence of risk factors for thrombotic disease; in all patients with moderate to severe COVID infections.2.To give therapeutic anticoagulation with unfractionated heparin if there is evidence of thromboembolism or high suspicion of thromboembolism. 3.If the patient is requiring oxygen to give Dexamethasone injection 6mg intravenously once daily for minimum duration of 10 days. 4.If significant respiratory support requirement; to consider prone ventilation; non-invasive or invasive ventilatory support and ICU care as needed.Other symptomatic and supportive measures", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Colchicine and Standard of care for the treatment of SARS-CoV-2 infection: All patients will be receiving loading dose of 1mg and thereafter once daily oral colchicine 0.5mg for a period of at least 3 weeks or till clinical improvement.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: The standard of care treatment of SARS-CoV-2 infection: The Standard of care for COVID infection as per institution protocol are:1.To give prophylactic anti-coagulation with unfractionated heparin- if D-dimer more than 500; presence of risk factors for thrombotic disease; in all patients with moderate to severe COVID infections.2.To give therapeutic anticoagulation with unfractionated heparin if there is evidence of thromboembolism or high suspicion of thromboembolism. 3.If the patient is requiring oxygen to give Dexamethasone injection 6mg intravenously once daily for minimum duration of 10 days. 4.If significant respiratory support requirement; to consider prone ventilation; non-invasive or invasive ventilatory support and ICU care as needed.Other symptomatic and supportive measures", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]